Rep. David Schweikert backs RFK Jr. on obesity and chronic disease issues; Bill would allow AIs to prescribe FDA-approved drugs

David Schweikert is serving his eighth term in the United States Congress. He holds a seat on the Ways and Means Committee and is the current Chairman of the Oversight Subcommittee.

David Schweikert is serving his eighth term in the United States Congress. He holds a seat on the Ways and Means Committee and is the current Chairman of the Oversight Subcommittee.

Rep. David Schweikert backs RFK Jr. on obesity and chronic disease issues; Bill would allow AIs to prescribe FDA-approved drugs

2024年9月25日 · U.S. Representative David Schweikert (AZ-01) delivered a speech on the House Floor this week that expanded on the newly-released Republican Response to the 2024 Economic Report of the President. The report found alarming, but not surprising statistics that display the potential devastating effects to the U.S. economy.

Rep. David Schweikert backs RFK Jr. on obesity and chronic disease issues; Bill would allow AIs to prescribe FDA-approved drugs

2025年1月9日 · Rep. David Schweikert backs RFK Jr. on obesity and chronic disease issues; Bill would allow AIs to prescribe FDA-approved drugs

2025年2月6日 · Rep. David Schweikert (R-Ariz.), who chairs the tax-writing panel’s subcommittee on oversight, warned against addressing expiring provisions of the 2017 tax law for families and businesses without addressing that bill’s impact on increasing debt and deficits.

2024年8月22日 · Rep. David Schweikert (R-Ariz.) has an expansive view of what he’s wishing will be up for debate when Congress tackles the expiring Trump tax cuts in 2025. He’s working now in the hopes that colleagues will think big next year.

Office Locations. Washington, DC Office 166 Cannon House Office Building Washington, DC 20515 Phone: (202) 225-2190 Fax: (202) 225-0096 Scottsdale Office